iRhythm Technologies Inc

Research iRhythm Technologies Inc (IRTC) on Bullrun: market cap USD 4.06B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 4.06B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 747.14M-USD 45.00MUSD 34.52M70.6%-1.39USD 236.01MUSD 731.18MUSD 152.75M
FY2024USD 591.84M-USD 113.00M-USD 30.55M68.9%-3.63USD 419.60MUSD 736.91MUSD 90.91M
FY2023USD 492.68M-USD 123.00M-USD 90.53M67.3%-4.04USD 36.17MUSD 34.95MUSD 210.10M
FY2022USD 410.92M-USD 116.00M-USD 52.84M68.5%-3.88USD 78.83MUSD 34.94MUSD 239.81M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 4.06Bn/an/an/a
20252025-12-31USD 5.73Bn/an/an/a
20242024-12-31USD 2.83Bn/an/an/a
20232023-12-29USD 3.28Bn/an/an/a
20222022-12-30USD 2.82Bn/an/an/a
20212021-12-31USD 3.47Bn/an/an/a

About iRhythm Technologies Inc

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is iRhythm Technologies Inc's market cap?

iRhythm Technologies Inc's market capitalization is USD 4.06B.

What does iRhythm Technologies Inc do?

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.